Objectives Randomised clinical trials (RCTs) are costly. We aimed to provide a systematic overview of the available evidence on resource use and costs for RCTs to support budget planning. Study Design and Setting We systematically searched MEDLINE, EMBASE and HealthSTAR from inception until November 30, 2016 without language restrictions. We included any publication reporting empirical data on resource use and costs of RCTs and categorised them depending on whether they reported (i) resource and costs of all aspects at all study stages of an RCT (including conception, planning, preparation, conduct, and all tasks after the last patient has completed the RCT); (ii) on several aspects, (iii) on a single aspect (e.g. recruitment); or (iv) on o...
Clinical trials evaluating medicines, medical devices, and procedures now commonly assess the econom...
AbstractObjectivesA growing number of prospective clinical trials include economic end points. Recog...
BACKGROUND: Over the past decade, annual funding for biomedical research has more than doubled while...
Randomized clinical trials (RCTs) are costly. We aimed to provide a systematic overview of the avail...
Objectives Randomised clinical trials (RCTs) are costly and published information on resource requir...
Objectives: We aimed to provide a systematic overview of freely available tools which may help plan ...
Healthcare costs, particularly pharmaceutical costs, are a dominant issue for most healthcare organi...
Background: A large fraction of the cost of conducting clinical trials is allocated to recruitment o...
Background: Electronic health records (EHRs) may support randomized controlled trials (RCTs). We aim...
AbstractBackgroundThe UK Health Technology Assessment (HTA) program funds trials that address issues...
AbstractClinical trials evaluating medicines, medical devices, and procedures now commonly assess th...
Background The preparation of a randomized controlled trial (RCT) requires substantial resources and...
Electronic health records (EHRs) may support randomized controlled trials (RCTs). We aimed to descri...
BackgroundThe preparation of a randomized controlled trial (RCT) requires substantial resources and ...
Background Many randomized controlled trials (RCTs) collect cost-effectiveness data. Without appropr...
Clinical trials evaluating medicines, medical devices, and procedures now commonly assess the econom...
AbstractObjectivesA growing number of prospective clinical trials include economic end points. Recog...
BACKGROUND: Over the past decade, annual funding for biomedical research has more than doubled while...
Randomized clinical trials (RCTs) are costly. We aimed to provide a systematic overview of the avail...
Objectives Randomised clinical trials (RCTs) are costly and published information on resource requir...
Objectives: We aimed to provide a systematic overview of freely available tools which may help plan ...
Healthcare costs, particularly pharmaceutical costs, are a dominant issue for most healthcare organi...
Background: A large fraction of the cost of conducting clinical trials is allocated to recruitment o...
Background: Electronic health records (EHRs) may support randomized controlled trials (RCTs). We aim...
AbstractBackgroundThe UK Health Technology Assessment (HTA) program funds trials that address issues...
AbstractClinical trials evaluating medicines, medical devices, and procedures now commonly assess th...
Background The preparation of a randomized controlled trial (RCT) requires substantial resources and...
Electronic health records (EHRs) may support randomized controlled trials (RCTs). We aimed to descri...
BackgroundThe preparation of a randomized controlled trial (RCT) requires substantial resources and ...
Background Many randomized controlled trials (RCTs) collect cost-effectiveness data. Without appropr...
Clinical trials evaluating medicines, medical devices, and procedures now commonly assess the econom...
AbstractObjectivesA growing number of prospective clinical trials include economic end points. Recog...
BACKGROUND: Over the past decade, annual funding for biomedical research has more than doubled while...